SAN JOSE — A South Bay biotech firm has bought a big San Jose office and research building in a deal that could enable the ...

DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Scotiabank analyst George Farmer maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of ...

William Blair analyst Sami Corwin maintained a Hold rating on Legend Biotech (LEGN – Research Report) today. The company’s shares ...

Legend Biotech jumped Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.

Heavily polluted water owing to illegal mining (galamsey) activities, is making it increasingly expensive for pharmaceutical ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

Novartis reports strong Q2 2024 sales, with Kesimpta and Pluvicto showing significant growth. Learn more about NVSEF stock ...

Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where ...